Faculty of Sexual and Reproductive Healthcare, Royal College of the Obstetricians and Gynaecologists (UK), 22 March 2023 FSRH response to new study on use of combined and progestogen-only hormonal contraception and breast cancer risk: A new observational study by Fitzpatrick, et al., published in PLOS Medicine investigated the association between current or recent use of combined oral and...
July/August 2020 The Therapeutic Goods Administration (TGA) advises: Consumers and health professionals are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone. The affected products are: Brevinor – norethisterone 0.5 mg and ethinylestradiol 35 micrograms Norimin – norethisterone 0.5 mg and ethinylestradiol 35...
SHINE SA, 15/4/2020 SHINE SA have released a new Fact Sheet for health professionals: Contraception During the COVID-19 Pandemic. Contraception is an essential service during the COVID-19 pandemic. This includes the provision of emergency contraception, access to long acting reversible contraception (LARC) and management of complications of LARC. Health professionals can continue to facilitate...
SHINE SA, November 2018 Clinicians: SHINE SA is pleased to present the following Clinical Forum by Dr Amy Moten on the topic of Contraception. This recording is available free of charge, and access is limited to three months only. This forum covers emergency contraception and new formulations of the Pill. 3 Category 2 RACGP Points can be awarded on completion of the forum. Recording length: 1...
Children by Choice, Last modified on: 22 May 2017 Contraceptive use is often compromised for women living with violence. Contraceptive options that are safe and appropriate for one woman may not work for another. If you’re working with women experiencing violence, it’s important to explore each woman’s unique circumstances and draw on her own knowledge to assess the degree of comfort...
POZ, October 20 2014
World Health Organization (WHO) guidelines cautioning against oral birth control for HIV-positive women taking antiretrovirals may be overly broad, according to new research.
Read more here